Found: 1
Select item for more details and to access through your institution.
Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation.
- Published in:
- Heart & Vessels, 2020, v. 35, n. 3, p. 312, doi. 10.1007/s00380-019-01499-7
- By:
- Publication type:
- Article